GNLX NASDAQ
Genelux Corporation
1W: -4.0%
1M: +15.0%
3M: +10.6%
YTD: -35.8%
1Y: +6.2%
3Y: -88.5%
$2.92
+0.00 (+0.00%)
Weekly Expected Move ±9.9%
$2
$3
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$109.8M
52W Range2.29-8.535
Volume75,694
Avg Volume185,728
Beta0.50
Dividend—
Analyst Ratings
Company Info
CEOThomas D. Zindrick
Employees24
SectorHealthcare
IndustryBiotechnology
IPO Date2023-01-26
Websitegenelux.com
2625 Townsgate Road
Westlake Village, CA 91361
US
Westlake Village, CA 91361
US
858 483 0024
About Genelux Corporation
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
Latest News
Genelux GAAP EPS of -$0.20
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
FY2029 Earnings Estimate for Genelux Issued By HC Wainwright
Genelux GAAP EPS of -$0.86 misses by $0.01
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Yu Yong | S-Sale | 605 | $2.97 | 2026-05-11 |
| Cappello Joseph | S-Sale | 605 | $2.97 | 2026-05-11 |
| Zindrick Thomas | S-Sale | 2,798 | $2.94 | 2026-05-11 |
| Smalling Ralph | S-Sale | 270 | $2.98 | 2026-05-11 |
| Smalling Ralph | S-Sale | 240 | $2.51 | 2026-03-25 |